scholarly article | Q13442814 |
P50 | author | Claire W Hallahan | Q88396796 |
P2093 | author name string | Mark Connors | |
Richard T Davey | |||
Julia A Metcalf | |||
John C Tilton | |||
Mary McLaughlin | |||
Alison J Johnson | |||
Marlise R Luskin | |||
Maura Manion | |||
P2860 | cites work | Limited durability of viral control following treated acute HIV infection | Q24804986 |
Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. | Q27469571 | ||
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2 | Q28202803 | ||
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 | ||
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency | Q33340517 | ||
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution | Q33932773 | ||
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation | Q33950164 | ||
HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment | Q34124001 | ||
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory | Q34190038 | ||
Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo | Q34717597 | ||
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes | Q35110576 | ||
Cell-Mediated Immunity to Varicella-Zoster Virus | Q35229935 | ||
The immune response to Epstein-Barr virus | Q35862731 | ||
Cell-mediated immunity and the outcome of hepatitis C virus infection | Q35919862 | ||
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells | Q36367286 | ||
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity | Q36371562 | ||
Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 | Q36474240 | ||
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
Cell-Mediated Immunity during Natural Measles Infection | Q37031815 | ||
Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency | Q37365738 | ||
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. | Q37384895 | ||
Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication | Q39683633 | ||
Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. | Q40400498 | ||
Impaired T cell proliferation in acute dengue infection | Q40639461 | ||
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation | Q40846653 | ||
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help | Q42642562 | ||
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression | Q43750477 | ||
Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load | Q43779427 | ||
Functional analysis of T lymphocyte subsets in antiviral host defense. | Q44098687 | ||
Ablation of CD8 and CD4 T cell responses by high viral loads | Q44259092 | ||
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation | Q44654522 | ||
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy | Q45721932 | ||
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination | Q45731214 | ||
Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors | Q45741753 | ||
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy | Q45743180 | ||
Mechanisms of Immunosuppression in Cytomegalovirus Mononucleosis. II. Virus-Monocyte Interactions | Q45801737 | ||
Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. | Q51024682 | ||
Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-gamma-secreting cells. | Q51985345 | ||
Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. | Q51995303 | ||
Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. | Q52011861 | ||
CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. | Q52014394 | ||
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. | Q52026668 | ||
Immune control of HIV-1 after early treatment of acute infection | Q56961920 | ||
Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection | Q78551235 | ||
Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction | Q81598419 | ||
Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions | Q81913313 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2713-2725 | |
P577 | publication date | 2006-12-20 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load | |
P478 | volume | 81 |
Q60321325 | A TGF-β mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children |
Q34987059 | Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. |
Q42229225 | Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults. |
Q36823297 | Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response |
Q34490157 | Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides |
Q35599441 | CD4 T cell depletion at the cervix during HIV infection is associated with accumulation of terminally differentiated T cells. |
Q37543246 | CTL quality and the control of human retroviral infections |
Q38098176 | Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. |
Q37301305 | Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus |
Q27487966 | Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness |
Q26827712 | Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines |
Q37410726 | Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. |
Q34507539 | Distinctive features of CD4+ T cell dysfunction in chronic viral infections |
Q33869222 | Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors |
Q35001377 | Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? |
Q56994404 | Elite control of HIV infection: implications for vaccine design |
Q36498230 | Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy |
Q40480304 | HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease. |
Q41762711 | HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. |
Q38682077 | HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV. |
Q37034594 | HIV-1-specific immune response. |
Q37866624 | HIV-specific CD4 T cells and immune control of viral replication |
Q37308147 | High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control |
Q36547178 | Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs |
Q36447548 | IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control |
Q34575451 | Immune mechanisms of HIV control |
Q56334451 | Impaired CMV Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres |
Q35339284 | Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys |
Q35621704 | Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. |
Q57325915 | Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses |
Q37054526 | Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control |
Q37804860 | Pathogenic Mechanisms of HIV Disease |
Q34430261 | Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function |
Q34420861 | Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection |
Q36315197 | Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study |
Q33769360 | Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression |
Q37700859 | Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection |
Q38491191 | Success and failure of the cellular immune response against HIV-1. |
Q81110823 | Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells |
Q34550760 | T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control |
Q30014840 | T-cell quality in memory and protection: implications for vaccine design |
Q33443913 | Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers |
Q38116710 | Unravelling the mechanisms of durable control of HIV-1. |
Q44297682 | Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction |